Cite

HARVARD Citation

    Yang, L. et al. (2014). Recent advances of immunotherapy in lung cancer: anti-programmed cell death-1/programmed death ligand-1 antibodies. Lung cancer management. pp. 175-190. [Online]. 
  
Back to record